Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2015 (2015), Article ID 769576, 3 pages
http://dx.doi.org/10.1155/2015/769576
Case Report

Neuroleptic Malignant Syndrome: A Case Aimed at Raising Clinical Awareness

Department of Internal Medicine, Thomas Jefferson University Hospital, 1025 Walnut Street, Jefferson College Building, Suite 805, Philadelphia, PA 19107, USA

Received 2 May 2015; Revised 4 June 2015; Accepted 7 June 2015

Academic Editor: Paul Dargan

Copyright © 2015 Jad Al Danaf et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. J. Gurrera, S. N. Caroff, A. Cohen et al., “An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method,” The Journal of Clinical Psychiatry, vol. 72, no. 9, pp. 1222–1228, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. K. C. Mills, “Serotonin syndrome. A clinical update,” Critical Care Clinics, vol. 13, no. 4, pp. 763–783, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. J. R. Strawn, P. E. Keck Jr., and S. N. Caroff, “Neuroleptic malignant syndrome,” American Journal of Psychiatry, vol. 164, no. 6, pp. 870–876, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Waldorf, “Update for nurse anesthetists: neuroleptic malignant syndrome,” Journal of the American Association of Nurse Anesthetists, vol. 71, no. 5, pp. 389–394, 2003. View at Google Scholar · View at Scopus
  5. V. R. Velamoor, “Neuroleptic malignant syndrome. Recognition, prevention and management,” Drug Safety, vol. 19, no. 1, pp. 73–82, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. E. W. Boyer and M. Shannon, “Current concepts: the serotonin syndrome,” The New England Journal of Medicine, vol. 352, no. 11, pp. 1112–1120, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. V. R. Velamoor, R. M. G. Norman, S. N. Caroff, S. C. Mann, K. A. Sullivan, and R. E. Antelo, “Progression of symptoms in neuroleptic malignant syndrome,” Journal of Nervous and Mental Disease, vol. 182, no. 3, p. 168, 1994. View at Publisher · View at Google Scholar · View at Scopus
  8. S. N. Caroff and S. C. Mann, “Neuroleptic malignant syndrome,” Medical Clinics of North America, vol. 77, no. 1, pp. 185–202, 1993. View at Google Scholar · View at Scopus
  9. P. Adnet, P. Lestavel, and R. Krivosic-Horber, “Neuroleptic malignant syndrome,” British Journal of Anaesthesia, vol. 85, no. 1, pp. 129–135, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Rosebush and T. Stewart, “A prospective analysis of 24 episodes of neuroleptic malignant syndrome,” American Journal of Psychiatry, vol. 146, no. 6, pp. 717–725, 1989. View at Publisher · View at Google Scholar · View at Scopus
  11. M. J. Bhanushali and P. J. Tuite, “The evaluation and management of patients with neuroleptic malignant syndrome,” Neurologic Clinics, vol. 22, no. 2, pp. 389–411, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. J. M. Davis, P. G. Janicak, P. Sakkas, C. Gilmore, and Z. Wang, “Electroconvulsive therapy in the treatment of the neuroleptic malignant syndrome,” Convulsive Therapy, vol. 7, no. 2, pp. 111–120, 1991. View at Google Scholar · View at Scopus
  13. Ü. Tural and E. Önder, “Clinical and pharmacologic risk factors for neuroleptic malignant syndrome and their association with death,” Psychiatry and Clinical Neurosciences, vol. 64, no. 1, pp. 79–87, 2010. View at Publisher · View at Google Scholar · View at Scopus